Delivery Order SPE2DB20D1109-SPE2DB24FP56W
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP15T, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,974.88 firm fixed-price delivery order is for the supply of 380 mg Vivitrol vials and diluents, a medication used for the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used to treat alcohol and opioid dependence. The contract has a ceiling value of $1,420.47 and runs through June 2024. It is a firm fixed price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award, valued at $13,733.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used in the treatment of alcohol and opioid dependence. The contract is structured as a Firm Fixed Price Delivery Order with a completion date of January 18, 2024. It is not designated as a set-aside contract,...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,273.59 firm-fixed-price delivery order contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of January 15, 2025. Additionally, AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $3,165.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. This is a Firm Fixed Price Delivery Order contract with a period of performance ending on March 28, 2025. The contract is not designated as a set-aside and was...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,007.02, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. The contract does not have a...
This federal contract award, valued at $12,964.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a division of Cencora, Inc. The contract is for the delivery of Vivitrol 380 mg vials with diluents, a medication used to treat alcohol and opioid dependence. The contract is a Firm Fixed Price Delivery Order with a completion date of November 10, 2022. Amerisourcebergen Drug Corp holds several Indefinite Delivery Contracts (IDCs) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,001.17, is for the delivery of Vivitrol 380 mg vial-diluents, a medication used in the treatment of alcohol and opioid dependence. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 3, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,314.48, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a completion date of June 6, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award....
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,657.24 firm-fixed-price delivery order contract is for the supply of VIVITROL 380 mg vials and diluents, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...